163 related articles for article (PubMed ID: 18245461)
1. Alterations in Gemin5 expression contribute to alternative mRNA splicing patterns and tumor cell motility.
Lee JH; Horak CE; Khanna C; Meng Z; Yu LR; Veenstra TD; Steeg PS
Cancer Res; 2008 Feb; 68(3):639-44. PubMed ID: 18245461
[TBL] [Abstract][Full Text] [Related]
2. Altered gene and protein expression by Nm23-H1 in metastasis suppression.
Lee JH; Marshall JC; Steeg PS; Horak CE
Mol Cell Biochem; 2009 Sep; 329(1-2):141-8. PubMed ID: 19415462
[TBL] [Abstract][Full Text] [Related]
3. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
[TBL] [Abstract][Full Text] [Related]
4. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.
Hartsough MT; Clare SE; Mair M; Elkahloun AG; Sgroi D; Osborne CK; Clark G; Steeg PS
Cancer Res; 2001 Mar; 61(5):2320-7. PubMed ID: 11280805
[TBL] [Abstract][Full Text] [Related]
5. Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2.
Horak CE; Mendoza A; Vega-Valle E; Albaugh M; Graff-Cherry C; McDermott WG; Hua E; Merino MJ; Steinberg SM; Khanna C; Steeg PS
Cancer Res; 2007 Dec; 67(24):11751-9. PubMed ID: 18089805
[TBL] [Abstract][Full Text] [Related]
6. Nm23-H1 homologs suppress tumor cell motility and anchorage independent growth.
McDermott WG; Boissan M; Lacombe ML; Steeg PS; Horak CE
Clin Exp Metastasis; 2008; 25(2):131-8. PubMed ID: 18058029
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds.
Ouatas T; Halverson D; Steeg PS
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3763-72. PubMed ID: 14506169
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of N-acetylglucosaminyltransferase V by tumorigenesis- or metastasis-suppressor gene and its relation to metastatic potential of human hepatocarcinoma cells.
Guo HB; Liu F; Zhao JH; Chen HL
J Cell Biochem; 2000 Sep; 79(3):370-85. PubMed ID: 10972975
[TBL] [Abstract][Full Text] [Related]
9. Gemin5 Binds to the Survival Motor Neuron mRNA to Regulate SMN Expression.
Workman E; Kalda C; Patel A; Battle DJ
J Biol Chem; 2015 Jun; 290(25):15662-15669. PubMed ID: 25911097
[TBL] [Abstract][Full Text] [Related]
10. Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells.
Boissan M; De Wever O; Lizarraga F; Wendum D; Poincloux R; Chignard N; Desbois-Mouthon C; Dufour S; Nawrocki-Raby B; Birembaut P; Bracke M; Chavrier P; Gespach C; Lacombe ML
Cancer Res; 2010 Oct; 70(19):7710-22. PubMed ID: 20841469
[TBL] [Abstract][Full Text] [Related]
11. A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest.
Howlett AR; Petersen OW; Steeg PS; Bissell MJ
J Natl Cancer Inst; 1994 Dec; 86(24):1838-44. PubMed ID: 7990158
[TBL] [Abstract][Full Text] [Related]
12. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity.
Leone A; Flatow U; VanHoutte K; Steeg PS
Oncogene; 1993 Sep; 8(9):2325-33. PubMed ID: 8395676
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the tumor metastasis suppressor nonmetastatic protein 23 homologue H1 and estrogen receptor alpha alters estrogen-responsive gene expression.
Curtis CD; Likhite VS; McLeod IX; Yates JR; Nardulli AM
Cancer Res; 2007 Nov; 67(21):10600-7. PubMed ID: 17975005
[TBL] [Abstract][Full Text] [Related]
14. CTCF and EGR1 suppress breast cancer cell migration through transcriptional control of Nm23-H1.
Wong KM; Song J; Wong YH
Sci Rep; 2021 Jan; 11(1):491. PubMed ID: 33436746
[TBL] [Abstract][Full Text] [Related]
15. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer.
Palmieri D; Halverson DO; Ouatas T; Horak CE; Salerno M; Johnson J; Figg WD; Hollingshead M; Hursting S; Berrigan D; Steinberg SM; Merino MJ; Steeg PS
J Natl Cancer Inst; 2005 May; 97(9):632-42. PubMed ID: 15870434
[TBL] [Abstract][Full Text] [Related]
16. CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer.
Loh TJ; Moon H; Cho S; Jang H; Liu YC; Tai H; Jung DW; Williams DR; Kim HR; Shin MG; Liao DJ; Zhou J; Shi W; Zheng X; Shen H
Oncol Rep; 2015 Sep; 34(3):1231-8. PubMed ID: 26151392
[TBL] [Abstract][Full Text] [Related]
17. Expression profile of genes associated with antimetastatic gene: nm23-mediated metastasis inhibition in breast carcinoma cells.
Zhao H; Jhanwar-Uniyal M; Datta PK; Yemul S; Ho L; Khitrov G; Kupershmidt I; Pasinetti GM; Ray T; Athwal RS; Achary MP
Int J Cancer; 2004 Mar; 109(1):65-70. PubMed ID: 14735469
[TBL] [Abstract][Full Text] [Related]
18. NM23 gene expression in human breast carcinomas: loss of correlation with cell proliferation in the advanced phase of tumor progression.
Caligo MA; Cipollini G; Berti A; Viacava P; Collecchi P; Bevilacqua G
Int J Cancer; 1997 Feb; 74(1):102-11. PubMed ID: 9036878
[TBL] [Abstract][Full Text] [Related]
19. [Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1].
Che GW; Zhou QH; Zhu W; Wang YP; Qin Y; Liu LX; Chen XH; Sun YL; Sun ZF
Ai Zheng; 2005 Mar; 24(3):278-84. PubMed ID: 15757527
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of the relationship between nm23-H1 gene and human chronic myeloblastic leukemia using siRNA].
Chen YX; Zhang MY; Xiong S; Qian CW; Wang YF
Sheng Wu Gong Cheng Xue Bao; 2006 May; 22(3):403-7. PubMed ID: 16755918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]